PLX

Peers: ANTX BDTX TNYA MOLN HURA MENS MSLE OKUR ORMP SPRB

Index	RUT	P/E	12.55	EPS (ttm)	0.18	Insider Own	3.88%	Shs Outstand	80.57M	Perf Week	3.60%
Market Cap	185.31M	Forward P/E	46.00	EPS next Y	0.05	Insider Trans	0.00%	Shs Float	77.45M	Perf Month	8.49%
Enterprise Value	142.00M	PEG	-	EPS next Q	-0.01	Inst Own	22.04%	Short Float	5.05%	Perf Quarter	9.00%
Income	15.33M	P/S	2.43	EPS this Y	343.75%	Inst Trans	-9.81%	Short Ratio	5.29	Perf Half Y	31.43%
Sales	76.38M	P/B	2.76	EPS next Y	-74.36%	ROA	17.40%	Short Interest	3.91M	Perf YTD	27.78%
Book/sh	0.83	P/C	3.58	EPS next 5Y	-	ROE	27.27%	52W High	3.19 -27.90%	Perf Year	58.62%
Cash/sh	0.64	P/FCF	14.25	EPS past 3/5Y	35.12% 17.78%	ROIC	20.64%	52W Low	1.36 69.12%	Perf 3Y	4.55%
Dividend Est.	-	EV/EBITDA	6.66	Sales past 3/5Y	3.45% -3.46%	Gross Margin	69.97%	Volatility	5.17% 4.04%	Perf 5Y	15.58%
Dividend TTM	-	EV/Sales	1.86	EPS Y/Y TTM	268.45%	Oper. Margin	25.91%	ATR (14)	0.10	Perf 10Y	-66.42%
Dividend Ex-Date	-	Quick Ratio	2.04	Sales Y/Y TTM	27.80%	Profit Margin	20.07%	RSI (14)	65.15	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.15	EPS Q/Q	567.37%	SMA20	10.52%	Beta	0.00	Target Price	11.00
Payout	-	Debt/Eq	0.13	Sales Q/Q	233.73%	SMA50	10.56%	Rel Volume	3.44	Prev Close	2.22
Employees	226	LT Debt/Eq	0.10	Earnings	May 13 BMO	SMA200	5.00%	Avg Volume	739.18K	Price	2.30
IPO	Apr 09, 1996	Option/Short	Yes / Yes	EPS/Sales Surpr.	2300.00% 193.48%	Trades		Volume	2,544,164	Change	3.60%

Protalix BioTherapeutics Inc

Upgrade your Finviz experience